
GOP Battle on Stude...


| SSRI | Sector Avg. | S&P 500 |
|---|---|---|
| 11.84 | 11.70 | 17.70 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -25.92 | -42.79 | -59.15 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 63.10 | 43.31 | 2.49 |
| Net Income | -31.60 | -5.16 | 0.00 |
| EPS | -31.30 | -4.58 | 0.00 |
| EBITDA | 65.08M |
| REVENUE | 241.12M |
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.07 | $-0.06 | $-0.17 | $-0.02 |
| Number of Analysts | 2 | 2 | 2 | 3 |
| High Estimate | $-0.02 | $-0.01 | $-0.11 | $0.11 |
| Low Estimate | $-0.13 | $-0.11 | $-0.22 | $-0.20 |
| Prior Year | $0.43 | $-0.03 | $0.68 | $-0.17 |
| Growth Rate (Year over Year) | -117.44% | -100.00% | -124.26% | 85.86% |